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Abstract
A recent trial utilizing central venous oxygen saturation (SCVO2) as
a resuscitation marker in patients with sepsis has resulted in its
inclusion in the Surviving Sepsis Campaign guidelines. We review
the evidence behind SCVO2 and its relationship to previous trials of
goal-directed therapy. We compare SCVO2 to other tools for
assessing the adequacy of resuscitation including physical
examination, biochemical markers, pulmonary artery catheterization,
esophageal Doppler, pulse contour analysis, echocardiography,
pulse pressure variation, and tissue capnometry. It is unlikely that
any single technology can improve outcome if isolated from an
organized pattern of early recognition, algorithmic resuscitation,
and frequent reassessment. This article includes a response to the
journal’s Health Technology Assessment questionnaire by the
manufacturer of the SCVO2 catheter.
Introduction
In 2001, Rivers and coworkers [1] reported findings from a
landmark investigation of early goal-directed therapy (EGDT)
for septic shock. They hypothesized that current resuscitation
strategies rely on inadequate indices of the adequacy of
perfusion, and that resuscitation titrated to central venous
oxygen saturation (ScvO2) would improve survival. In their trial,
protocol-driven resuscitation of patients with systemic
inflammatory response syndrome (SIRS) and a systolic blood
pressure below 90 mmHg (after a 30 ml/kg fluid challenge) or
a blood lactate concentration of 4 mmol/l or greater resulted in
a hospital mortality rate of 30.5%, which was significantly less
than the mortality rate (46.5%) in the cohort randomly assigned
to usual care. As a result of this single-center randomized trial,
the use of ScvO2 was given a grade B recommendation in the
recent Surviving Sepsis Campaign recommendations [2].
The study’s findings are compelling, but the universal
adoption of the ‘Rivers protocol’ would require a departure
from current practice in many institutions. The results from the
study by Rivers and colleagues have stimulated debate in the
fields of critical care and emergency medicine. One of the
central questions in this debate is whether it is necessity to
use measurements of ScvO2 to guide resuscitation. Is ScvO2
essential to the EGDT approach, or might other, alternative
indices of the adequacy of resuscitation serve as well or
better? In view of this debate, our aims here are to review
briefly previous sepsis resuscitation studies and discuss
factors that may have made EGDT successful as compared
with previous attempts, and to examine other currently
available markers of resuscitation.
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What is the science underlying the technology?
Edwards Presep Central Venous Oximetry catheters measure
oxygen concentration in venous blood via reflection
spectrophotometry. Because deoxygenated hemoglobin and
oxyhemoglobin absorb light differently at selected
wavelengths, the reflected light can be analyzed to determine
the percentage of ScvO2. This measurement is continuous
and updates every 2 s.350
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What are the primary indications for its use?
The primary indication for the use of Presep is as a part of
EGDT in the detection and treatment of patients with early
sepsis. These patients may present in the emergency room, in
the wards, or in the intensive care unit.
What are the common secondary indications for its use?
Mixed venous oxygen saturation (SvO2) has for some time been
used as a guide to resuscitation adequacy in critically ill patients.
Use of ScvO2, as a surrogate for SvO2, is indicated in critically ill
patients requiring monitoring for resuscitation in whom
placement of a pulmonary artery catheter is not warranted.
What are the efficacy data to support its use, including
data over an existing gold standard, if appropriate?
The accuracy of SvO2 measurement via spectrophotometry is
very well documented and considered the ‘gold standard’.
Over the past 10 years many papers have been written to
assess the usability of ScvO2 as a surrogate for SvO2 [3-5].
Are there any appropriate impact data available on the
following: outcome, therapy, clinician behaviour
The majority of evidence to support the use of Presep ScvO2
catheters comes from the work of Rivers and coworkers [6],
but there are also a number of optimization studies using
forms of goal-directed therapy and SvO2 from groups such as
that of Polonen [7] that show beneficial outcomes
summarized in Dr Shoemakers’ meta-analysis [8]. The
Surviving Sepsis Campaign announced guidelines for the
treatment of sepsis [9], including EGDT guided by ScvO2.
Workers from St Georges Hospital have just presented an
abstract at ESICM on ScvO2 monitoring in high-risk surgery
[10].
What are the costs of using the technology, both initial
and ongoing?
To utilize the Edwards Presep ScvO2 catheter one requires
hardware in the form of a module from a major patient monitor
company or an Edwards oxygen saturation monitoring device
(e.g. Vigilance, Explorer, SAT2, among others). In addition,
one Edwards Presep oximetry catheter is required per
patient.
Are there be any special user or patient requirements
for the safe and effective use of this technology?
The beauty of this minimally invasive technology is that it only
requires the insertion of a standard central venous catheter
using the Seldinger technique. A single calibration is required
before insertion; subsequent calibrations can be perfomed in
vivo through a simple venous blood sample. All patients
eligible for central venous catheter placement can receive the
benefits of this technology.
What is the current status of this technology and, if it is
not in widespread use, why not?
Since its release only 6 months ago in Europe and the USA,
2500 patients have received continuous ScvO2 monitoring;
its sister parameter, SvO2, is continuously measured in more
than 300,000 patients a year and has been available for
15 years.
What additional research is necessary or pending?
EGDT using ScvO2 has proven efficacy in the emergency
room. Studies are currently being conducted to supplement
the work done in sepsis in the intensive care unit (ICU), with
research settings including congestive heart failure, trauma
and high-risk surgery.
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Early goal-directed therapy in comparison with previous
resuscitation studies
Clinical research in resuscitation end-points increased after
Shoemaker and coworkers [11] reported that mortality was
decreased when high-risk surgical patients were titrated to
so-called supranormal values for cardiac index (≥4.5 l/min per
m2) and oxygen delivery (≥600 ml/min per m2). However, two
large multicentric randomized controlled trials (RCTs)
conducted by Hayes [12] and Gattinoni [13] and their
coworkers failed to corroborate the findings obtained by the
Shoemaker group. Indeed, in the study by Hayes and
colleagues [12], the mortality rate actually was significantly
greater for patients randomly assigned to be resuscitated to
supranormal indices than it was for patients assigned to usual
care. Why did these RCTs not show a positive effect on
mortality? It is important to examine carefully the factors that
may contribute to the success or failure of a single center RCT
that is discordant with the results of multicenter RCTs [14].
Factors that might influence outcome include resuscitation
protocol, resuscitation end-points and the technologies used
to measure those end-points, timing of interventions, and
baseline mortality rate. Because of the bundled nature of care
during resuscitation and the complex pathophysiology
underlying sepsis, it may be difficult to identify any one single
factor that strongly determines outcome.
Lack of blinding
It is difficult or impossible to achieve adequate blinding in
trials designed to compare resuscitation strategies. To
overcome the potential for bias introduced by the absence of
blinding, investigators have stressed the importance of using
protocolized care for both the intervention and control arms.
In the trial conducted by Rivers and coworkers [1], control
individuals were resuscitated using an algorithm that included
the administration of fluid boluses titrated to increase central
venous pressure (CVP) to 8–12 mmHg. Vasopressors were351
titrated to maintain mean arterial pressure between 65 and
90 mmHg. Maintaining urine output at 0.5 ml/kg per hour or
greater was also a stated resuscitation target, although the
strategies to be used to achieve this goal were not specified.
Of individuals in the control group, 86% achieved these
hemodynamic and urine output targets, whereas 99% of
those in the intervention group achieved hemodynamic and
ScvO2 goals [1].
Transfusion trigger
Data obtained in a large multicentric RCT support the view
that a liberal red cell transfusion policy designed to maintain
hemoglobin concentration at 10 g/dl or greater may be
deleterious in stable, critically ill patients [15]. However, the
effects of red blood cell transfusion during the resuscitation
of acutely ill, septic patients may be different. Both Hayes
[12] and Gattinoni [13] and coworkers used the same
threshold for transfusion (hemoglobin concentration
<10 g/dl) as was used by Rivers and colleagues [1].
Timing of intervention
A recent meta-analysis [16] suggested that aggressive
resuscitation efforts that begin early (before the onset of
organ failure) may prove more beneficial than resuscitation
carried out after the establishment of organ failure. Gattinoni
and coworkers [13] enrolled patients in the SvO2 trial after
48 hours in the ICU, and Hayes and colleagues [12] enrolled
patients upon arrival at the ICU, irrespective of the time from
the presumed onset of critical illness. Thus, both of these
(negative) studies enrolled patients who were already in an
ICU. In contrast, Rivers and colleagues [1] enrolled patients
on presentation to the emergency department. These patients
had already received 6 hours of protocolized care before their
arrival in the ICU. Thus, early identification and initiation of
treatment may be a key element in the effectiveness of
resuscitation interventions. Perhaps by actively enrolling
individuals with cryptic sepsis or compensated shock, Rivers
and colleagues intervened at a point before multisystem
organ dysfunction had developed.
Selection of patients
Rivers and coworkers [1] enrolled only patients with a
suspected infection presenting to the emergency department
with two out of four SIRS criteria and hypotension after a fluid
bolus or an elevated blood lactate concentration. Thus, the
study focused on patients with clear evidence of tissue
hypoperfusion. In contrast, both the Hayes [12] and Gattinoni
[13] studies enrolled a diverse population of critically ill
patients at varying times throughout their illness.
Indices of the adequacy of resuscitation
In the intervention (experimental) arms of both the Hayes [12]
and Gattinoni [13] trials, the goals for resuscitation were
indices (cardiac index and systemic oxygen delivery) that are
usually measured using a pulmonary artery catheter (PAC). In
contrast, the end-point for resuscitation in the trial by Rivers
and coworkers [1] was a parameter (ScvO2) that was mea-
sured by using an oximetric central venous catheter. Is it
possible that the positive results in the study by Rivers and
colleagues were simply due to the difference in the primary
end-point for resuscitation? Although it is hard to be certain,
this notion seems improbable to us. Recall that the trial
performed by Gattinoni and coworkers [13] included a third
arm in which patients were resuscitated to a SvO2 of greater
than 70% (measured using a PAC). The patients in this arm
of the study did not fair any better than those in the other two
arms.
Alternatives to monitoring central venous oxygen
saturation to guide resuscitation
Adding an oximetric probe to a central venous catheter allows
continuous measurement of ScvO2. Whether measurements
of ScvO2 are a reasonable surrogate for measurements of
SvO2 is controversial. Although the absolute values of ScvO2
are almost always higher than values for SvO2, Rivers and
colleagues [17] maintain that the two parameters track one
another closely over a range of hemodynamic states. This
notion, however, was recently challenged [18]. The
advantage of using an oximetric central venous catheter as
compared with a PAC is that the former device can be
inserted more rapidly and is less expensive. Placement of an
oximetric central venous catheter also may be associated
with fewer complications, although this idea has never been
rigorously tested.
If we accept that the use of an oximetric central line was not
the sole reason for success in the Rivers trial, then are there
other resuscitative markers that may serve as adequate end-
points for an early goal-directed strategy? Many markers and
technologies have promise in guiding resuscitation. However,
currently, no one marker is perfect.
Physical examination
Physical examination and vital signs have traditionally been
used to screen for hypovolemia and/or shock. However, heart
rate, blood pressure, and capillary refill are not sensitive
predictors of hypovolemia [19]. Moreover, these ‘vital signs’
do not correlate with other indicators of shock that require
more invasive methods for measurement. In one study [20],
50% of critically ill patients presenting with shock and
resuscitated to normal vital signs continued to have elevated
blood lactate levels and low ScvO2.
Recently, there has been considerable interest in pulse
pressure or systolic pressure variation as clinical predictors of
preload responsiveness, but these signs predict the response
to fluid loading – not whether fluid is likely to beneficial [21].
Nevertheless, it seems reasonable to hypothesize that
optimizing preload will improve outcome, particularly if the
strategy is instituted early in the course of illness (e.g. during
the first 6 hours after presentation). Normalization of blood
lactate level or base deficit might also be of value, but
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continuous monitoring of blood pH or lactate concentration is
not currently available in most centers.
Biochemical parameters
Circulating levels of procalcitonin [22], TREM-1 [23],
molecules associated with induction of apoptosis (e.g. tumor
necrosis factor and Fas ligand) [24], interleukin-6 [25], and
other biochemical indices of inflammation have been
proposed as diagnostic markers of sepsis and SIRS. These
markers may be clinically useful in the initial diagnosis and
stratification of sepsis [26], but these parameters are not
useful for the minute-to-minute titration of care.
It is well established that a high blood lactate concentration
portends a poor prognosis for patients with shock due to
various causes [27-32]. Furthermore, a prompt decrease in
circulating lactate level in response to resuscitation is a good
prognostic indicator [33]. These considerations notwith-
standing, measurements of blood lactate concentration are
not useful for the titration of resuscitation because this
biochemical parameter responds too slowly to changes in
perfusion and, by itself, blood lactate concentration provides
no information regarding key parameters such as preload
responsiveness.
Invasive hemodynamic monitoring
The goal of resuscitation is to ensure adequate oxygen delivery
to tissues. At the level of the whole body, oxygen delivery is the
product of cardiac output and arterial oxygen content. In septic
shock, the predominant reason for low cardiac output is
inadequate preload. CVP is often used as a surrogate for
preload [34]. However, even direct measurements of left atrial
pressure do not correlate perfectly with left ventricular end-
diastolic volume (i.e. preload), because the relationship
between intracavitary volume and pressure is inconsistent both
among patients and in the same patient over time [35,36].
CVP, of course, is even less likely than left atrial pressure to
reflect left ventricular end-diastolic volume accurately, because
it is affected by right ventricular afterload (i.e. pulmonary arterial
pressure) as well as right ventricular compliance.
For many years, the PAC was considered the ‘gold standard’
for monitoring systemic hemodynamic parameters, such as
cardiac output, left ventricular preload, and systemic oxygen
delivery. The PAC can be used to measure central venous
and pulmonary artery pressures. Using thermodilution, this
device permits repetitive or even continuous estimates of
cardiac output. In addition, whether by using oximetric
technology or blood gas analysis, the PAC permits measure-
ments of systemic oxygen delivery, SvO2, and systemic
oxygen extraction ratio.
In 1996, Connors and coworkers [37] reported surprising
results in a major observational study evaluating the value of
pulmonary artery catheterization in critically ill patients. Those
investigators took advantage of an enormous data set that
had previously been (and prospectively) collected for another
purpose at five major teaching hospitals in the USA. They
compared two groups of patients: those who did and those
who did not undergo placement of a PAC during their first
24 hours of ICU care. They recognized that the value of their
intended analysis was completely dependent on the
robustness of their methodology for case matching, because
sicker patients (i.e. those at greater risk for mortality based on
the severity of their illness) were presumably more likely to
undergo pulmonary artery catheterization. Accordingly, the
authors used sophisticated statistical methods for generating
a cohort of study (i.e. PAC) patients, each one having a
paired control matched carefully for severity of illness. A
critical assessment of their published findings supports the
view that the cases and their controls were indeed well
matched with respect to a large number of pertinent clinical
parameters. Remarkably, Connors and coworkers concluded
that placement of a PAC during the first 24 hours of stay in
an ICU is associated with a significant increase in the risk for
mortality, even when statistical methods are used to account
for severity of illness.
Although the report by Connors and coworkers [37]
generated an enormous amount of controversy in the medical
community, the results reported actually confirmed the results
of two prior similar observational studies. The first of these
studies [38] used a database of 3263 patients with acute
myocardial infarction treated in central Massachusetts in
1975, 1978, 1981, and 1984 as part of the Worcester Heart
Attack Study. For all patients, hospital mortality was
significantly greater for patients treated using a PAC, even
when multivariate statistical methods were employed to
control for key potential confounding factors. The second
large observational study of patients with acute myocardial
infarction [39] also found that hospital mortality was
significantly greater for patients managed with the assistance
of a PAC, even when the presence or absence of ‘pump
failure’ was considered in the statistical analysis. In neither of
these earlier reports did the authors conclude that placement
of a PAC was truly the cause of worsened survival after
myocardial infarction. As a result of the study by Connors and
coworkers, experts in the field questioned the value of
bedside pulmonary artery catheterization, and some even
called for a moratorium on the use of the PAC [40].
Since publication of the ‘Connors study’ [37], a large
observational study of patients admitted to a medical ICU
[41] concluded that patients who underwent placement of a
PAC were sicker than those who did not receive this type of
monitoring. However, risk-adjusted mortality was similar for
patients treated with and those treated without use of a PAC.
Relatively few prospective RCTs of pulmonary artery
catheterization have been performed. All of these studies are
flawed in one or more ways. The study by Pearson and
coworkers [42] was very underpowered; only 226 patients
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were enrolled. In addition, the attending anesthesiologists
were permitted to exclude patients from the CVP group at
their discretion; thus, randomization was compromised. The
study by Tuman and coworkers [43] was large (1094
patients were enrolled), but different anesthesiologists were
assigned to the different groups. Furthermore, 39 patients in
the CVP group underwent placement of PAC because of
hemodynamic complications. All of the individual single-
institution studies of vascular surgery patients were relatively
underpowered [44-47], and all excluded at least certain
categories of patients (e.g. those with a history of recent
myocardial infarction).
In the largest RCT to evaluate the use of the PAC, Sandham
and coworkers [48] randomly assigned 1994 high-risk
patients undergoing major thoracic, abdominal, or orthopedic
surgery to placement of a PAC or a CVP catheter. In the
patients assigned to receive a PAC, physiologic goal-directed
therapy was implemented by protocol. There were no
differences at 30 days, 6 months, or 12 months in mortality
between the two groups, and ICU length of stay was similar.
There was a significantly higher rate of pulmonary emboli in
the PAC group (0.9% versus 0%). This study has been
criticized because most of the patients enrolled were not in
the highest risk category.
The limitations of these studies notwithstanding, the weight of
current evidence suggests that routine use of the PAC is not
useful for the vast majority of patients undergoing cardiac,
major peripheral vascular, or ablative surgical procedures.
Whether use of a PAC for early goal-directed resuscitation of
patients with sepsis would lead to results better or worse
than those obtained by Rivers and coworkers [1] is not
known. It is clear, however, that if routine placement of a
central venous catheter would stress the capabilities of most
emergency departments, then routine PAC placement would
be even more problematic.
Doppler ultrasonography
When ultrasonic sound waves are reflected by moving
erythrocytes in the bloodstream, the frequency of the
reflected signal is increased or decreased, depending on
whether the cells are moving toward or away from the
ultrasound source. This change in frequency is called the
Doppler shift, and its magnitude is determined by the velocity
of the moving red blood cells. Thus, measurements of
Doppler shift can be used to calculate red blood cell velocity.
With knowledge of both the cross-sectional area of a
vessel and the mean red blood cell velocity of the blood
flowing through it, one can calculate blood flow rate. If the
vessel in question is the aorta, then cardiac output can be
calculated.
Two approaches have been developed for using Doppler
ultrasonography to estimate cardiac output. The first
approach uses an ultrasonic transducer, which is manually
positioned in the suprasternal notch and focused on the root
of the aorta. Aortic cross-sectional area can be estimated
using a nomogram (that factors in age, height, and weight),
back calculated if an independent measure of cardiac output
is available, or by using two-dimensional transthoracic or
transesophageal ultrasonography. Although this approach is
completely noninvasive, it requires a highly skilled operator in
order to obtain meaningful results and is quite labor intensive.
Moreover, unless cardiac output measured using thermo-
dilution is used to back calculate aortic diameter, accuracy
using the suprasternal notch approach is not acceptable
[49,50]. Accordingly, the method is useful only for obtaining
very intermittent estimates of cardiac output and has not
been widely adopted by clinicians.
Another more promising approach was originally introduced
by Daigle and colleagues [51]. In this method, blood flow
velocity is continuously monitored in the descending thoracic
aorta using a transducer introduced into the esophagus. The
current embodiment of this concept, called the CardioQ, is
manufactured by Deltex Medical Limited (Chichester, UK).
The device consists of a continuous wave Doppler
transducer mounted at the tip of a transesophageal probe. In
order to maximize the accuracy of the device, the probe
position must be adjusted to obtain the peak velocity in the
aorta. To transform blood flow in the descending aorta into
cardiac output, a correction factor is applied, which is based
on the assumption that only a portion of the flow at the root of
the aorta is still present in the descending thoracic aorta.
Aortic cross-sectional area is estimated using a nomogram
based on the patient’s age, weight, and height. Results using
these methods appeared to be sufficiently accurate across a
broad spectrum of patients to be clinically useful [52]. In that
multicenter study, good correlation was found between
cardiac output measurements obtained using the esophageal
Doppler method and thermodilution. The ultrasound device
also calculates a derived parameter, called flow time
corrected (FTc), which is the systolic flow time in the
descending aorta corrected for heart rate. FTc is a function of
preload, contractility, and vascular input impedance. Although
it is not a pure measure of preload, Doppler-based estimates
of stroke volume and FTc have been used successfully to
guide volume resuscitation in high-risk surgical patients
undergoing major operations [53]. Indeed, evidence is
accumulating that esophageal Doppler monitoring coupled
with algorithmic resuscitation improves outcomes in surgical
patients [54,55].
Impedance cardiography
The impedance to flow of alternating electrical current in
regions of the body is commonly called ‘bioimpedance’. In the
thorax, changes in the volume and velocity of blood in the
thoracic aorta lead to detectable changes in bioimpedance.
The first derivative of the oscillating component of thoracic
bioimpedance (dZ/dt) is linearly related to aortic blood flow.
On the basis of this relationship, empirically derived formulas
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have been developed to estimate stroke volume (and hence
cardiac output) noninvasively. This methodology is called
impedance cardiography. The approach is attractive because
it is completely noninvasive, provides a continuous read-out
of cardiac output, and does not require extensive training for
use. Despite these advantages, a number of studies suggest
that measurements of cardiac output obtained by impedance
cardiography are not sufficiently reliable to be used for
clinical decision making and have poor correlation with
standard methods such as thermodilution and ventricular
angiography [56-58].
Pulse contour analysis
Perhaps one of the least invasive and most appealing
methods for determining cardiac output uses an approach
called pulse contour analysis, originally described by
Wesseling and colleagues [59] for estimating stroke volume
on a beat-to-beat basis. The mechanical properties of the
arterial tree and stroke volume determine the shape of the
arterial pulse waveform. The pulse contour method of
estimating cardiac output uses the arterial pressure waveform
as an input in a model of the systemic circulation in order to
determine beat-to-beat stroke volume. The parameters of
resistance, compliance, and impedance are initially estimated
based on the patient’s age and sex, and can be subsequently
refined by using a reference standard measurement of
cardiac output. A commercially available device, the PulseCO
Hemodynamic Monitor (LiDCO, Ltd, London, UK) utilizes this
technology. In the LiDCO system, the reference standard
estimation of cardiac output is obtained periodically using the
indicator dilution approach by injecting the indicator (a dilute
solution of lithium ion) into a central venous catheter and
detecting the transient increase in lithium ion concentration in
the blood using an arterial catheter equipped with a lithium-
sensitive sensor in a femoral artery.
Measurements of cardiac output based on pulse contour
monitoring are comparable in accuracy to standard PAC
thermodilution methods, but they use an approach that is
much less invasive because arterial and central venous, but
not transcardiac, catheterization is needed [60]. Using online
pressure waveform analysis, the computerized algorithms can
calculate stroke volume, cardiac output, systemic vascular
resistance, and an estimate of myocardial contractility, namely
the rate of rise in arterial systolic pressure (dP/dT). One
weakness of the pulse contour approach is that it does not
directly provide an assessment of preload responsiveness.
However, this information can be obtained by analyzing
changes in pulse pressure over the respiratory cycle in
mechanically ventilated patients (see below).
The use of pulse contour analysis has been applied using an
even less invasive technology based on totally noninvasive
photoplethysmographic measurements of arterial pressure
[61]. However, the accuracy of this technique has been
questioned [62] and its clinical utility remains to be determined.
Partial carbon dioxide rebreathing
Partial carbon dioxide rebreathing uses the Fick principle to
estimate cardiac output noninvasively. By intermittently
altering the dead space within the ventilator circuit via a
rebreathing valve, changes in carbon dioxide production
(VCO2) and end-tidal carbon dioxide (ETCO2) are used to
determine cardiac output using a modified Fick equation
(cardiac output = ∆VCO2/∆ETCO2) [63]. A commercially
available device, the NICO monitor (Novametrix Medical
Systems, Inc., Wallingford, CT, USA) uses this Fick principle
to calculate cardiac output using intermittent partial carbon
dioxide rebreathing through a disposable rebreathing loop.
The device consists of a carbon dioxide sensor based on
infrared light absorption, an airflow sensor, and a pulse
oximeter. Changes in intrapulmonary shunt and hemodynamic
instability impair the accuracy of cardiac output estimated by
partial carbon dioxide rebreathing. Continuous in-line pulse
oximetry and fractional inspired oxygen are used to estimate
shunt fraction to correct the cardiac output value obtained.
Some studies of the partial carbon dioxide rebreathing
approach suggest that the accuracy of the NICO system is
not good when thermodilution is used as the gold standard
for measuring cardiac output [64,65]. However, other studies
suggest that the partial carbon dioxide rebreathing method
for determination of cardiac output compares favorably with
measurements made using a PAC in critically ill patients [66].
Like some of the other minimally invasive methods discussed
above, the NICO system does not provide a direct
assessment of preload responsiveness.
Transesophageal echocardiography
Transesophageal echocardiography (TEE) has made the
transition from operating room to the ICU. TEE requires that
the patient be sedated. Using this powerful technology,
global assessments of left and right ventricular function can
be conducted, including determinations of ventricular volume,
ejection fraction, and cardiac output. Segmental wall motion
abnormalities, pericardial effusions, and tamponade can
readily be identified with TEE. Doppler techniques allow
estimation of atrial filling pressures. The technique is
somewhat cumbersome and requires considerable training
and skill in order to obtain reliable results.
Analysis of pulse pressure variation with respiration
When intrathoracic pressure increases during the application
of positive airway pressure in mechanically ventilated
patients, venous return decreases and, as a consequence,
stroke volume also decreases. Therefore, pulse pressure
variation (PPV) during a positive pressure breath can be used
to predict the responsiveness of cardiac output to changes in
preload [67]. PPV is defined as the difference between the
maximal pulse pressure and the minimum pulse pressure
divided by the average of these two pressures [67]. Michard
and colleagues [67] validated this approach by comparing
PPV, CVP, pulmonary artery occlusion pressure, and systolic
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pressure variation as predictors of preload responsiveness in
a cohort of critically ill patients. They classified patients as
being preload responsive if their cardiac index increased by
at least 15% after rapid infusion of a standard volume of
intravenous fluid. Receiver operating characteristic curves
demonstrated that PPV was the best predictor of preload
responsiveness. Although atrial arrhythmias can interfere with
the usefulness of this technique [21], PPV remains a very
useful approach for assessing preload responsiveness in
most patients because of its simplicity and reliability.
Tissue capnometry
Global indices of cardiac output or systemic oxygen delivery
provide little useful information regarding the adequacy of
cellular oxygenation and mitochondrial function. On theoretical
grounds, measuring tissue pH to assess the adequacy of
perfusion is an extremely attractive concept. As a
consequence of the stoichiometry of the reactions responsible
for the substrate level phosphorylation of ADP to form ATP,
anaerobiosis is inevitably associated with the net accumulation
of protons [68]. Accordingly, knowing that tissue pH is not in
the acid range should be enough information to conclude that
global perfusion (and, for that matter, arterial oxygen content)
are sufficient to meet the metabolic demands of the cells, even
without knowledge of the actual values for tissue blood flow or
oxygen delivery. By the same token, the detection of tissue
acidosis should alert the clinician to the possibility that
perfusion is inadequate. Prompted by this reasoning, Fiddian-
Green and colleagues [65,69,70] promulgated the idea that
tonometric measurements of tissue partial carbon dioxide
tension (PCO2) in the stomach or sigmoid colon could be used
to estimate mucosal pH (‘pHi’) and thereby monitor visceral
perfusion in critically ill patients.
Unfortunately, the notion of using tonometric estimates of
gastrointestinal mucosal pH for monitoring perfusion is
predicated on a number of assumptions, some of which may
be partially or completely invalid. Furthermore, currently
available methods for performing measurements of gastric
mucosal PCO2 in the clinical setting remain rather
cumbersome and expensive. Perhaps for these reasons,
gastric tonometry for monitoring critically ill patients has never
really caught on except as a research tool. Some recent
developments in the field may be changing this situation,
however, and monitoring tissue PCO2 may become a practical
means for assessing the adequacy of perfusion.
Although PCO2 and pH are affected by changes in perfusion
in all tissues, efforts to monitor these parameters in patients
using tonometric methods have focused on the mucosa of
the gastrointestinal tract, particularly the stomach, for both
practical and theoretical reasons. From a practical standpoint,
the stomach is already commonly intubated in clinical
practice for purposes of decompression and drainage or
feeding. Placement of a nasogastric or orogastric tube is
generally regarded as minimally invasive. In addition, when
global perfusion is compromised, blood flow to the
splanchnic viscera decreases to a greater extent than does
perfusion to the body as a whole [71]. Thus, a marker of
compromised splanchnic perfusion should be a ‘leading
indicator’ of impending adverse changes in blood flow to
other organs [72]. Second, the gut has been hypothesized to
be the ‘motor’ of the multiple organ system dysfunction
syndrome [73], and in experimental models intestinal mucosal
acidosis, whether due to inadequate perfusion or other
causes, has been associated with hyperpermeability to
hydrophilic solutes [74,75]. Therefore, ensuring adequate
splanchnic perfusion might be expected to minimize
derangements in gut barrier function and, on this basis,
improve outcome for patients.
The stomach, however, may not be an ideal location for
monitoring tissue PCO2. First, carbon dioxide can be formed
in the lumen of the stomach when hydrogen ions secreted by
parietal cells in the mucosa titrate luminal bicarbonate anions,
which are present either as a result of backwash of duodenal
secretions or secretion by gastric mucosal cells. Thus,
measurements of gastric PCO2 and pHi can be confounded
by gastric acid secretion, as documented in a study of normal
volunteers by Heard and coworkers [76] and subsequently
confirmed by others [77-79]. Consequently, accurate
measurements of gastric PCO2 and pHi depend on pharmaco-
logic blockade of luminal proton secretion using histamine
receptor antagonists or proton pump inhibitors. The need to
use pharmacologic therapy adds to the cost and complexity of
the monitoring strategy. Second, enteral feeding can interfere
with measurements of gastric mucosal PCO2, necessitating
temporary cessation of the administration of nutritional
support or the placement of a postpyloric tube [80].
Despite the problems noted above, measurements of gastric
pHi and/or mucosal–arterial PCO2 gap have been shown to
be good predictors of outcome in a wide variety of critically ill
individuals, including general medical ICU patients [81,82],
victims of multiple trauma [83-85], patients with sepsis [86],
and patients undergoing major surgical procedures [70,87].
In studies using endoscopic measurements of gastric
mucosal blood flow by laser Doppler flowmetry, the
development of gastric mucosal acidosis has been shown to
correlate with mucosal hypoperfusion [88]. The development
of low pHi in the colon has been shown to correlate with an
exaggerated host inflammatory response in patients
undergoing aortic surgery [73]. Moreover, in a landmark
prospective multicentric RCT of monitoring in medical ICU
patients, titrating resuscitation to a gastric pHi end-point
rather than conventional hemodynamic indices resulted in
higher 30-day survival [89]. In another study, Ivatury and
coworkers [90] randomly assigned 57 trauma patients to two
groups. In the first group, administration of fluids and
vasoactive drugs was titrated to achieve a gastric pHi greater
than 7.30. In the second group, resuscitation was titrated to
achieve a calculated systemic oxygen delivery index greater
Available online http://ccforum.com/content/9/4/349356
than 600 ml/min per m2 or systemic oxygen utilization greater
than 150 ml/min per m2. Although survival was not
significantly different in the two arms of the study, failure to
normalize gastric pHi within 24 hours was associated with a
very high mortality rate (54%), whereas normalization of pHi
was associated with a significantly lower mortality rate (7%).
It seems likely that monitoring tissue PCO2 (‘tissue
capnometry’) will play an increasingly important role in the
management of critically ill patients because of two important
insights. First, the directly measured parameter, namely tissue
PCO2, provides more reliable information about perfusion than
does the derived parameter pHi [91-93]. By eliminating the
potentially confounding effects of systemic hypocapnia or
hypercapnia, monitoring the gap between tissue PCO2 and
arterial carbon dioxide tension (PaCO2) may prove to be even
more valuable than simply following changes in tissue PCO2.
The second recent insight is that it may not be necessary, or
even desirable, to monitor tissue PCO2 in the stomach or
other portions of gastrointestinal tract. For example, Sato and
coworkers [94] showed that changes in gastric wall and
esophageal tissue PCO2 track each other very closely in rats
subjected to hemorrhagic shock. Similar results were
reported by Guzman and coworkers [95] in a study of dogs
infused with lipopolysaccharide. It appears probable that
monitoring tissue PCO2 in other nongastric sites, such as the
space under the tongue, may require even less invasion of the
patient and yet be as informative as measuring PCO2 in the
wall of the esophagus or the gut [96,97].
Results from preliminary clinical studies support the view that
monitoring tissue PCO2 in the sublingual mucosa may provide
valuable clinical information. Increased sublingual carbon
dioxide tension (PslCO2) was associated with a decrease in
arterial blood pressure and cardiac output in patients with
shock due to hemorrhage or sepsis [98]. In a study of
critically ill patients with septic or cardiogenic shock, the
PslCO2–PaCO2 gradient was found to be a good prognostic
indicator [99]. This study also demonstrated that sublingual
capnography was superior to gastric tonometry in predicting
patient survival. The PslCO2–PaCO2 gradient also correlated
with the mixed venous–arterial PCO2 gradient, but it failed to
correlate with blood lactate level, SvO2, or systemic oxygen
delivery. These latter findings suggest that the PslCO2–PaCO2
gradient may be a better marker of tissue dysoxia than are
these other parameters. Similar findings were reported in
another study conducted by Marik and Bankov [100]. A
device for sublingual capnometry, the CapnoProbe (Tyco
Healthcare/Nellcor, Pleasonton, CA, USA), was being
marketed commercially. The device was voluntarily recalled
by the manufacturer in 2004, however, following hospital
reports showing that Burkholderia cepacia, a pathogenic
bacterium, could be cultured both from samples from patients
monitored with CapnoProbes and from unused CapnoProbe
sensors. A variety of other potentially pathogenic bacteria
species were cultured from unused CapnoProbe sensors.
Conclusion
It is unlikely that placement of an oximetric central venous
catheter alone without integration into an organized program
of early recognition, algorithmic resuscitation, and frequent
reassessment would improve sepsis mortality. Current levels
of evidence do not support the full-scale adoption of ScvO2
monitoring to the exclusion of all other modalities. Sorting out
what parts of the ‘Rivers resuscitation package’ affect sepsis
mortality remains an important task. Use of the ScvO2
catheter (or any other monitoring strategy) without an
organized program of care will be unsuccessful.
The best level of evidence that currently exists is from a single-
center RCT. There are two, equally valid but mutually exclusive
options: remain skeptical of adopting a new technology and
treatment strategy that requires a major revision in the current
standard of care until further data from a multicentric RCT are
available; or adopt the technology (and protocol) with an
attitude of cautious optimism and await the results of a
definitive multicenter RCT. With either option, further research
is imperative to address these questions. Can the results
obtained by Rivers and coworkers [1] be replicated in a
multicentric trial? What components of the ‘Rivers protocol’
are essential (e.g. is aggressive blood transfusion really
needed)? Can the results obtained by Rivers and cowokers
[1] be replicated even when less invasive forms of monitoring
(e.g. esophageal Doppler-based estimates of cardiac output
and preload responsiveness) are substituted for
measurements of ScvO2? What is the biochemical basis for
the apparent success of the ‘Rivers protocol?’
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